Literature DB >> 21245458

Quality of stroke prevention care in atrial fibrillation: many moving targets.

Mintu P Turakhia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21245458     DOI： 10.1161/CIRCOUTCOMES.110.959890

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  3 in total

1.  Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients.

Authors:  Jenna M Faircloth; Kristin M Miner; Tarek Alsaied; Nicole Nelson; Julie Ciambarella; Tomoyuki Mizuno; Joseph S Palumbo; Alexander A Vinks; Gruschen R Veldtman
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

Review 2.  Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?

Authors:  Jenny I Shen; Mintu P Turakhia; Wolfgang C Winkelmayer
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-11       Impact factor: 2.894

3.  Standardized warfarin monitoring decreases adverse drug reactions.

Authors:  Lisa B E Shields; Paula Fowler; Diane M Siemens; Douglas J Lorenz; Kenneth C Wilson; Steven T Hester; Joshua T Honaker
Journal:  BMC Fam Pract       Date:  2019-11-07       Impact factor: 2.497
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.